Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Sep;68 Suppl 2(Suppl 2):S60-S63.
doi: 10.1016/j.ihj.2016.02.011. Epub 2016 Feb 28.

Hemolysis induced by PMIVSD occluder

D Sheshagiri Rao  1 , Ramachandra Barik  2 , Akula Siva Prasad  3
Affiliations
Case Reports

Hemolysis induced by PMIVSD occluder

D Sheshagiri Rao et al. Indian Heart J. 2016 Sep.

Abstract

Hemolysis related to occluder, prosthetic valve, and prosthetic ring used for mitral valve annuloplasty are not very unusual. However, hemolysis related to transcathetor closure of post-myocardial infarction ventricular septal defect (PMIVSD) is infrequent. A close follow-up for spontaneous resolution with or without blood transfusion has been reported in a few cases. Occasionally, surgical retrieval is unavoidable or lifelong blood transfusion is required if surgery cannot be done because of higher risk. In this illustration, we have showed a close follow-up of a case of hemolysis induced by atrial septal occluder used for VSD closure after myocardial infarction. Despite successful device closure of PMIVSD which is difficult, a close watch is needed for complications like residual leak, device embolization, and hemolysis.

Keywords: Atrial septal occluder (ASO); Hemolysis; Post-myocardial infarction ventricular septal defect (PMIVSD); Transcathetor closure (TCC).

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) 2D echo shows a large ventricular defect of size 2.1 cm in middle part of interventricular septum with mid-distal septal aneurysm; (B) Coronary angiogram in right anterior oblique (RAO) view shows critical type B stenosis in the middle part of LAD which was stented and the scene angiogram shows atrial septal occluder (Cardi-O-Fix, 28 mm) across the ventricular septal defect immediately following the TCC; (C) Echo shows a stable and better aligned device plugging the VSD at the end of one-month follow-up; (D) Serial changes in color of urine from 2nd day device closure till the day of discharge.
See this image and copyright information in PMC

References

    1. Egbe A.C., Poterucha J.T., Rihal C.S. Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: the Mayo Clinic experience. Catheter Cardiovasc Interv. 2015;86:1264–1270. - PubMed
    1. Xu X.-D., Liu S.X., Liu X. Percutaneous closure of postinfarct muscular ventricular septal defects: a multicenter study in China. J Cardiol. 2014;64:285–289. - PubMed
    1. Turner M.S., Hamilton M., Morgan G.J., Martin R.P. Percutaneous closure of post-myocardial infarction ventricular septal defect: patient selection and management. Interv Cardiol Clin. 2013;2:173–180. - PubMed
    1. Ali T.A., Fatimi S.H., Hasan B.S. Transcatheter closure of a traumatic ventricular septal defect using an amplatzer™ atrial septal occluder device. Catheter Cardiovasc Interv. 2013;82:569–573. - PubMed
    1. Martinez M.W., Mookadam M., Mookadam F. A case of hemolysis after percutaneous ventricular septal defect closure with a device. J Invasive Cardiol. 2007;19:E192–E194. - PubMed